SCHEMBL9409164

SCHEMBL9409164

CCOC(=O)c1ccccc1Nc1cc(C(N)=O)c(C(=O)OC)cc1Nc1ccccc1C(=O)OCC

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 6/20 0.57
CDC25A P30304 1/20 0.57
CDC25C P30307 1/20 0.57
KDM4E B2RXH2 5/20 0.52
HSD17B10 Q99714 3/20 0.52
ALDH1A1 P00352 6/20 0.52
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HPGD P15428 1/20 0.51
MAPT P10636 2/20 0.50
TSHR P16473 2/20 0.50
METTL3 Q86U44 1/20 0.50
ALOX15 P16050 1/20 0.50
SIRT2 Q8IXJ6 1/20 0.50
MAPK1 P28482 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9409092 0.95 CDC25B (0.63) CDC25BCDC25ACDC25CKDM4EHSD17B10
SCHEMBL9409100 0.91 MAPT (0.59) KDM4EHSD17B10ALDH1A1LMNAHPGD
SCHEMBL9409083 0.89 MAPT (0.61) KDM4EHSD17B10ALDH1A1LMNAHPGD
SCHEMBL24494688 0.84 CDC25B (0.63) CDC25BCDC25ACDC25CKDM4EHSD17B10
SCHEMBL9409047 0.84 MAPT (0.55) CDC25BKDM4ELMNAHPGDMAPT
SCHEMBL9409103 0.83 ALDH1A1 (0.50) KDM4EHSD17B10ALDH1A1LMNASMN1; SMN2
SCHEMBL9409337 0.82 CSF1R (0.49) KDM4EHSD17B10ALDH1A1SMN1; SMN2HPGD
SCHEMBL9409108 0.80 TSHR (0.51) KDM4EHSD17B10ALDH1A1LMNAHPGD
SCHEMBL9409039 0.80 SIRT2 (0.56) KDM4EALDH1A1LMNASMN1; SMN2HPGD
SCHEMBL9409193 0.79 CDC25B (0.60) CDC25BCDC25ACDC25CKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0600832-A1 Derivatives of diamino benzoic and diamino phthalic acid und their use as protein linase inhibitors CIBA-GEIGY AG (CH) 1994-06-08 EP disclosed